Meeting Overview | We are pleased to invite you to the Multidisciplinary Expert Practice SM in Breast Cancer in Brussels, Belgium on 12-13 November 2010.
During this case-based meeting, leaders in the field discuss with participants, in an interactive format, clinical issues encountered daily by practicing physicians.
The Multidisciplinary Workshop on Friday will include 5 clinical scenarios for which attendees will be asked to provide their diagnostic and therapeutic opinions. A renowned, multidisciplinary faculty will review imaging, histology slides, and surgical techniques.
For available travel grants, please contact: travelgrants@prIMEoncology.org. |
Target Audience | This educational activity is designed for Pan-European medical oncologists, radiation oncologists, surgical oncologists, pathologists and other healthcare providers involved active in the management of patients with breast cancer. |
Meeting Venue | The Brussels Marriott Hotel
Rue Auguste Orts 3-7/ Grand Place
1000 Brussels, Belgium |
Faculty |
| Co-Chairs: |
|
|
Christos Markopoulos, MD, PhD
Athens University Medical School
Athens, Greece |
|
Cornelis van de Velde, MD, PhD
Leiden University
Leiden, the Netherlands |
| |
|
|
| Faculty: |
|
|
Ahmad Awada, MD, PhD
Institute Jules Bordet
Brussels, Belgium |
|
Robert Coleman, MD
Weston Park Hospital
Sheffield, United Kingdom |
Ian Kunkler, MD
University of Edinburgh
Edinburgh, Scotland |
|
Ariel Saracco, MD
Bröstcentrum SöS
Södersjukhuset
Stockholm, Sweden
|
Giuseppe Viale, MD, PhD
European Institute of Oncology
Milan, Italy
|
|
|
|
 Agenda |
| Friday, 12 November 2010 |
|
17.00-
19.00
|
|
Multidisciplinary Workshop
The how, when, and why of modern breast cancer management
Christos Markopoulos, MD, PhD; Cornelis van de Velde, MD, PhD; Ariel Saracco, MD; Giuseppe Viale, MD, PhD
|
| 19.30 |
|
Reception and buffet dinner |
| Saturday, 13 November 2010 |
| 07.30 |
|
Breakfast |
| 08.30 |
|
Welcome and demographic questions
prIME Medical Director/Co-chairs |
| 08.50 |
|
Hot topics in breast oncology in 2010
Rob Coleman, MD; Ian Kunkler, MD;
Christos Markopoulos, MD, PhD; Giuseppe Viale, MD, PhD |
| 09.30 |
|
Case #1—Endocrine-responsive postmenopausal breast cancer - a clinicopathology discussion
All Faculty |
| 10.15 |
|
Bone-targeted agents: What’s new and what’s next?
Robert Coleman, MD |
| 10.30 |
|
Break |
| 10.50 |
|
Case #2—T3 breast cancer in a postmenopausal patient
Cornelis van de Velde, MD, PhD |
| 11.20 |
|
Case #3—HER2-positive breast cancer in a premenopausal patient with cardiac risk - a clinicopathology discussion
All Faculty |
| 12.05 |
|
Clinical opinion poll questions |
| 12.30 |
|
Lunch |
| 13.30 |
|
Case #4—Managing metastatic breast cancer in a patient previously treated with an anthracycline and taxane
Ahmad Awada, MD, PhD |
| 14.00 |
|
Triple-negative breast cancer (TNBC): A demographic and molecular perspective
Giuseppe Viale, MD, PhD |
| 14.20 |
|
Case #5—Metastatic TNBC
Ahmad Awada, MD, PhD |
| 14.50 |
|
Case #6—Metastatic HER2-positive breast cancer with CNS metastases - a clinicopathology discussion
All Faculty |
| 15.30 |
|
Program “pearls” and concluding remarks
Christos Markopoulos, MD, PhD
Cornelis van de Velde, MD, PhD |
| 15.45 |
|
Adjourn |
|

|
|
|
 Accreditation | This meeting is accreditated by
'Multidisciplinary Expert Practice in Breast Cancer Management’ is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.
‘Multidisciplinary Expert Practice in Breast Cancer Management’ is designated for a maximum of 8 hours of European external CME credits. Each Medical Specialist should claim only those hours of credit that he/she actually spent in the educational activity.
EACCME credits are recognized by the American Medical Association towards the Physician’s Recognition Award (PRA). To convert EACCME credit to AMA PRA Category 1Credit ™ , contact the AMA.
This meeting is endorsed by ESSO.
 |
Organizer | This meeting is a prIME Oncology activity.
|
|